NTRA
Natera, Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables):
amplitud de titulares -4.8% ·
flujo de acciones +1.9% ·
nuevas posiciones netas -5.0%
· fórmula
Acumulación concentrada: acciones en aumento entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 215.03K | $85.48M | n/a | −1 |
| Q2 2026 | 160 | 0 | 103.68M | $28.12B | +5 | −6 |
| Q1 2026 | 164 | +3 | 98.65M | $19.54B | +6 | −4 |
| Q4 2025 | 160 | 0 | 102.31M | $23.44B | +1 | n/a |
| Q3 2025 | 23 | +1 | 81.70M | $13.15B | +1 | −1 |
| Q2 2025 | 20 | -1 | 57.32M | $9.68B | n/a | −1 |
| Q1 2025 | 18 | 0 | 31.15M | $4.40B | n/a | n/a |
| Q4 2024 | 18 | 0 | 26.97M | $4.27B | n/a | n/a |
| Q3 2024 | 17 | -1 | 21.42M | $2.72B | n/a | −1 |
| Q2 2024 | 18 | n/a | 16.29M | $1.76B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 12.68M | n/a | $2.14B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | T. Rowe Price ✦ | 12.19M | +15.7% | $2.06B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 3 | BlackRock ✦ (pasivo) | 10.96M | n/a | $1.85B | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 4 | State Street Global Advisors ✦ (pasivo) | 3.32M | -1.6% | $560.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Duquesne Family Office ✦ | 3.09M | -9.3% | $521.21M | 13.3% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.63M | -13.9% | $444.94M | 0.1% | ▼ Trim | 5 | SEC ↗ ×4 |
| 7 | Geode Capital Management ✦ (pasivo) | 2.55M | +7.0% | $430.64M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | AQR Capital Management ✦ | 1.73M | +44.6% | $291.72M | 0.2% | ▲ Add | 5 | SEC ↗ ×6 |
| 9 | Norges Bank ✦ (pasivo) | 1.64M | +14.8% | $277.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 1.45M | n/a | $245.41M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 11 | Capital World Investors ✦ | 1.41M | +255.6% | $238.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | ARK Investment Management ✦ | 936.39K | -0.7% | $158.19M | 1.2% | ▼ Trim | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 821.45K | -61.3% | $138.77M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Renaissance Technologies ✦ | 493.80K | +42.0% | $83.42M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 483.24K | +29.3% | $81.64M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 252.44K | +230.2% | $42.65M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 235.00K | -62.4% | $39.70M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 18 | Millennium Management ✦ | 176.51K | -31.0% | $29.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 173.80K | -28.5% | $29.36M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 20 | Gotham Asset Management ✦ | 101.61K | -11.3% | $17.17M | 0.1% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Marshall Wace | $37.41M | era 0.1% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 755 tenedores, 120.14M acciones, $20.15B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 60 acc. · $24,097
Director · 35 acc. · $14,232
Director · 80 acc. · $32,484
Director · 90 acc. · $36,333
Director · 142 acc. · $56,651
Director · 280 acc. · $112,189
Director · 80 acc. · $32,749
Director · 50 acc. · $20,258
Director · 215 acc. · $85,858
Director · 98 acc. · $40,116
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología